Virtual Screening, Database Development and Design
We attempt to use bioprogramming in PERL, R and use software platforms such as GROMACS, CLC BIO GENOMICS workbench, BLAST2GO, MGRAST, Modeller etc to analyse complex biological data sets and come up with meaningful insights on genomics, metagenomics as well as genome mutation data. We also engage ourselves towards the development of databases and tools for computational analysis
Two most important and established techniques which utilises the Next Generation Sequencing Based methods for biological data generation are transcriptome and Metagenome sequencing. While the former provides insights into the exact transcriptome dynamics of a particular organism in a particular timeframe, the latter is used for the analyses of the microbial communities in a particular region in an either time or experimental condition specific manner. The basic steps following the sequencing run is more or less similar involving assembly, annotation, prediction of repetitive sequences and pathway analyses. However, the target reference databases and genomes differ and in case of transcriptome analyses, for organisms who do not have their complete genome sequenced as yet, de novo transcriptome analyses is performed for proper elucidation of the RNAome. However, if we consider the soil plant continuum concept, then an integration of these two techniques might enable us to properly understand the genetic responses of plants in context of the rhizospheric microorganisms, soil profiles and abiotic stress parameters such as salinity or heavy metal enrichment.
The relevance of the non-coding genome to human disease has mainly been studied in the context of the widespread disruption of microRNA (miRNA) expression and function that is seen in human cancer. However, we are only beginning to understand the nature and extent of the involvement of non-coding RNAs (ncRNAs) in disease. Other ncRNAs, such as PIWI-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), tRNA derived microRNAs and long non coding RNAs are emerging as key elements of cellular homeostasis. Along with microRNAs, dysregulation of these ncRNAs is being found to have relevance not only to tumorigenesis, but also to neurological, cardiovascular, developmental and other diseases. tRNAs are characterized by their evolutionarily conserved secondary and tertiary structures, extensive post-transcriptional processing and modifications (up to 100 nucleoside modifications have been described), extreme stability and resistance to nucleases. Moreover, the human genome contains more than 500 genes encoding over 40 different tRNAs. Identification of novel ncRNAs derived from tRNAs, known as tRNA-derived RNA fragments, has recently gained significant attention. Some of these fragments are derived from precursor tRNA molecules, others from mature cytoplasmic tRNAs. The list of possible functions of tRNA-derived fragments is growing. The recent discovery that the abundance of 5'-tRNA halves found in sperm and oocytes rapidly decreases upon fertilization suggests that this class of molecules can be physiologically regulated. Similarly, 5'-tRNA halves and 5'-tRFs are found in exosomes within semen. tRNAs and tRNA fragments has been reported as novel sources of piRNAs (PIWI-interacting RNAs) in both mouse gametes and zygotes as well as in human somatic cells. The functions of these tRNA-derived piRNAs are not known but may be connected to epigenetic inheritance, silencing of retrotransposons and other genetic elements or post-transcriptional regulation of mRNAs. Finally, tRNA fragments are also induced by viral infections such as by Respiratory Syncytial Virus (RSV).
Thus as we attempt to quantify the functions of these small molecules in diseases, it is imperative to devise plan of actions to regulate, control and suppress their activities, such that the onset of diseases can be prevented. This project aims to explore the efficacy of antisense oligonucleotides as a mechanism for controlling the function of these non coding small molecules. Both wet lab and computational techniques would be explored for mining, predicting and validating the interactions of the designed antisense oligonucleotides to their respective targets as well as identify the efficacy of these interactions through RNA sequencing.
Background: Aminoacyl-tRNA Synthetases (aaRSs) are well known for their role in the translation process. Lately investigators have discovered that this family of enzymes are also capable of executing a broad repertoire of functions that not only impact protein synthesis, but extend to a number of other activities. Till date, transcriptional regulation has so far only been described in E. coli Alanyl-tRNA synthetase and it was demonstrated that alaRS binds specifically to the palindromic DNA sequence flanking the gene's transcriptional start site and thereby regulating its own transcription.
Objective: In the present study, we have characterized some of the features of the alaRS-DNA binding using various biophysical techniques.
Methods: To understand the role of full length protein and oligomerization of alaRS in promoter DNA binding, two mutants were constructed, namely, N700 (a monomer, containing the N-terminal aminoacylation domain but without the C-terminal part) and G674D (previously demonstrated to form full-length monomer). Protein-DNA binding study using fluorescence spectroscopy, analytical ultracentrifugation, Isothermal Titration Calorimetry was conducted.
Results: Sedimentation equilibrium studies clearly demonstrated that monomeric variants were unable to bind promoter DNA. Isothermal Calorimetry (ITC) experiment was employed for further characterization of wild type alaRS-DNA interaction. It was observed that full length E. coli Alanyl-tRNA synthetase binds specifically with its promoter DNA and forms a dimer of dimers. On the other hand the two mutant variants were unable to bind with the DNA.
Conclusion: In this study it was concluded that full length E. coli Alanyl-tRNA synthetase undergoes a conformational change in presence of its promoter DNA leading to formation of higher order structures. However, the exact mechanism behind this binding is currently unknown and beyond the scope of this study.
Structural insights and evaluation of the potential impact of missense variants on the interactions of SLIT2 with ROBO1/4 in cancer progression
The cognate interaction of ROBO1/4 with its ligand SLIT2 is known to be involved in lung cancer progression. However, the precise role of genetic variants, disrupting the molecular interactions is less understood. All cancer-associated missense variants of ROBO1/4 and SLIT2 from COSMIC were screened for their pathogenicity. Homology modelling was done in Modeller 9.17, followed by molecular simulation in GROMACS. Rigid docking was performed for the cognate partners in PatchDock with refinement in HADDOCK server. Post-docking alterations in conformational, stoichiometric, as well as structural parameters, were assessed. The disruptive variants were ranked using a weighted scoring scheme.
In silico prioritisation of 825 variants revealed 379 to be potentially pathogenic out of which, about 12% of the variants, i.e. ROBO1 (14), ROBO4 (8), and SLIT2 (23) altered the cognate docking. Six variants of ROBO1 and 5 variants of ROBO4 were identified as "high disruptors" of interactions with SLIT2 wild type. Likewise, 17 and 13 variants of SLIT2 were found to be "high disruptors" of its interaction with ROBO1 and ROBO4, respectively. Our study is the first report on the impact of cancer-associated missense variants on ROBO1/4 and SLIT2 interactions that might be the drivers of lung cancer progression.
Work Covered in Medical Science News
https://www.news-medical.net/news/20201021/SARS-CoV-2-mutations-possibly-making-virus-less-virulent.aspx
Assessing the Biodiversity and Conservation of Ferns of Sunderbans through Metagenomic Profiling
https://www.fernmetagenomedb.in/